NCT04582097View on ClinicalTrials.gov

Ramipril in Pediatric Patients on Hemodialysis

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

135

Participants

Timeline

Start Date

December 1, 2018

Primary Completion Date

March 1, 2019

Study Completion Date

February 28, 2020

Conditions
Hemodialysis
Interventions
DRUG

Ramipril

angiotensin-converting enzyme inhibitor

DRUG

placebo

same odor, color and size as the drug but without the active ingredient

Trial Locations (1)

Unknown

Ain Shams University Hospital, Cairo

All Listed Sponsors
lead

Ain Shams University

OTHER

NCT04582097 - Ramipril in Pediatric Patients on Hemodialysis | Biotech Hunter | Biotech Hunter